Powered by: Motilal Oswal
2025-08-01 04:01:09 pm | Source: Accord Fintech
Neogen Chemicals moves up as its arm incorporates wholly owned subsidiary
Neogen Chemicals moves up as its arm incorporates wholly owned subsidiary

Neogen Chemicals is currently trading at Rs. 1550.50, up by 8.25 points or 0.53% from its previous closing of Rs. 1542.25 on the BSE.

The scrip opened at Rs. 1547.95 and has touched a high and low of Rs. 1570.00 and Rs. 1540.20 respectively. So far 1390 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2414.90 on 10-Dec-2024 and a 52 week low of Rs. 1397.45 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 1580.75 and Rs. 1515.65 respectively. The current market cap of the company is Rs. 4094.44 crore.

The promoters holding in the company stood at 51.23%, while Institutions and Non-Institutions held 30.32% and 18.45% respectively.

Neogen Chemicals’ wholly owned subsidiary -- Neogen Ionics has incorporated wholly owned subsidiary named ‘Neogen Morita New Materials’ (NMNML) i.e. Step-Down Subsidiary of Neogen Chemicals on July 30, 2025. 

NMNML is incorporated with the main object to address growth opportunities in Lithium- Ion Battery material space, especially related to electrolyte Salts needed for internal consumption for electrolytes as well as to meet global market demand. Further, Neogen Ionics is in advance discussion with Morita Chemicals Industries Co. of Japan for formation of a Joint Venture Company in India and to facilitate the same NMNML is incorporated. 

Neogen Chemicals is specializing in Bromine based compounds, Grignard Reagents and Inorganic Lithium Salts.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here